UNIT 9 Nursing management of patients with disorders of Integumentary system
𧬠Review of Anatomy and Physiology of the Skin
π Definition:
The skin is the largest organ of the human body. It serves as a protective barrier between the internal organs and the external environment and plays vital roles in temperature regulation, sensory reception, immune defense, and vitamin D synthesis.
𧱠ANATOMY OF THE SKIN:
The skin is made up of three main layers:
1οΈβ£ Epidermis (Outer Layer)
Avascular (contains no blood vessels)
Composed of stratified squamous epithelial cells
Provides a protective barrier against environmental damage
π Layers of Epidermis (from inner to outer):
Stratum basale (germinativum) β deepest layer; site of cell division and melanin production
Stratum spinosum β provides strength and flexibility
Stratum granulosum β contains keratohyalin granules for keratin formation
Stratum lucidum β present only in thick skin (palms, soles)
Stratum corneum β outermost, made of dead keratinized cells for waterproof protection
π¬ Cell Types in Epidermis:
Keratinocytes β produce keratin for strength and waterproofing
Melanocytes β produce melanin pigment (skin color and UV protection)
Langerhans cells β immune defense
Merkel cells β touch sensation
2οΈβ£ Dermis (Middle Layer)
Thickest skin layer
Made of connective tissue, collagen, and elastin fibers
Provides strength, elasticity, and nourishment to the epidermis
Highly vascularized and innervated
π Divided into:
Papillary layer β contains capillaries, pain and touch receptors
The health history focuses on collecting relevant information from the patient about current symptoms, past conditions, lifestyle, and risk factors affecting the skin, hair, and nails.
β A. Presenting Complaints (Chief Concerns):
Ask the patient about:
Rash, redness, swelling, or discoloration
Itching (pruritus)
Pain, burning, tingling, or stinging
Dryness or peeling of skin
Wounds, ulcers, or sores that wonβt heal
Lesions, bumps, or moles that have changed in size, shape, or color
Nail discoloration or thickening
Hair loss or unusual hair growth
Excessive sweating (hyperhidrosis) or dry skin (xerosis)
π Ask about onset, location, duration, pattern, progression, and relieving/aggravating factors.
β B. Past Medical and Surgical History:
History of chronic skin conditions: eczema, psoriasis, acne, dermatitis, vitiligo
Dermatitis is a general term for inflammation of the skin, characterized by redness (erythema), swelling, itching (pruritus), and sometimes blistering, oozing, scaling, or thickening of the skin.
It is not a specific disease, but rather a broad classification of inflammatory skin conditions caused by allergens, irritants, infections, or immune reactions.
π Dermatitis can be acute (sudden onset) or chronic (long-standing and recurring).
𧬠Causes of Dermatitis:
The causes vary depending on the type of dermatitis but generally include:
π 1. Allergic Reactions:
Contact with allergens (e.g., poison ivy, nickel, cosmetics, fragrances)
Immune system reacts with Type IV hypersensitivity
π΅ 2. Irritants:
Direct skin damage from chemicals, detergents, solvents, soaps, or cleaning products
π’ 3. Genetic Factors:
Family history of atopic conditions (eczema, asthma, hay fever)
Common in atopic dermatitis
π£ 4. Infections:
Bacterial (e.g., impetiginized eczema)
Fungal (e.g., seborrheic dermatitis)
Viral (e.g., herpetic eczema)
π‘ 5. Environmental Triggers:
Heat, cold, humidity, sweating
Sun exposure (photodermatitis)
π΄ 6. Stress and Hormonal Factors:
Emotional stress can trigger or worsen dermatitis
Hormonal changes (e.g., puberty, menstruation)
β« 7. Autoimmune and Systemic Disorders:
E.g., Stasis dermatitis from poor circulation
Contact dermatitis due to delayed-type immune response
π’ Types of Dermatitis
Dermatitis is broadly classified based on its cause, appearance, and pathophysiology. Below are the major types:
1οΈβ£ Atopic Dermatitis (Eczema)
𧬠A chronic, relapsing, allergic skin condition, often starting in childhood
Use cool compresses or oatmeal baths to soothe itching
Keep skin clean and moisturized using unscented emollients
Encourage gentle pat-drying after bathing (no rubbing)
Trim fingernails short to prevent skin damage from scratching
Use hypoallergenic soap and laundry products
Dress the patient in soft, breathable clothing (e.g., cotton)
πΉ 2. Infection Prevention:
Maintain skin hygiene and wound care
Monitor for signs of secondary bacterial infection: warmth, redness, swelling, pus
Use aseptic technique when applying dressings
Educate on avoiding scratching or breaking blisters
Apply barrier creams for patients at risk of moisture-related dermatitis (e.g., incontinence)
πΉ 3. Medication Administration and Monitoring:
Administer:
Antihistamines for itching (e.g., cetirizine, diphenhydramine)
Oral antibiotics if infection is present
Topical or systemic corticosteroids as ordered
Monitor for side effects of steroids (skin thinning, increased blood sugar with systemic use)
Document effectiveness of medications
πΉ 4. Patient and Family Education:
Educate on:
Avoiding known triggers (chemicals, allergens, fabrics, heat, stress)
Proper use and timing of topical medications
Importance of moisturizing daily
When to seek help (fever, spreading redness, yellow drainage)
Encourage allergy testing if contact or atopic dermatitis is suspected
Teach about lifestyle adjustments: reducing stress, dietary changes if applicable
πΉ 5. Psychosocial Support:
Address concerns about appearance, body image, and social embarrassment
Encourage participation in support groups (especially for chronic cases like eczema or psoriasis)
Support coping strategies for stress-related dermatitis
π III. Evaluation (Expected Outcomes):
β Patient reports reduction in itching and discomfort β Skin lesions heal without infection or scarring β Patient demonstrates correct use of medications and skin care practices β Patient identifies and avoids triggers β Maintains intact, healthy skin and stable emotional well-being
β οΈ COMPLICATIONS OF DERMATITIS
If untreated, poorly managed, or frequently recurrent, dermatitis can lead to various complications:
π΄ 1. Secondary Bacterial Infections
Scratching leads to breaks in skin β entry of Staphylococcus or Streptococcus
Results in impetigo, cellulitis, or abscess formation
May require antibiotics or incision & drainage
π 2. Chronic Lichenification
Repeated scratching causes skin to thicken, darken, and become leathery
Often seen in chronic atopic or neurodermatitis
π‘ 3. Skin Atrophy
Prolonged use of topical corticosteroids may cause thinning of skin, visible blood vessels, or stretch marks
π’ 4. Pigment Changes
After healing, lesions may leave hyperpigmentation (dark spots) or hypopigmentation (light spots)
More noticeable in dark-skinned individuals
π΅ 5. Sleep Disturbances
Constant itching and discomfort may cause insomnia, irritability, and fatigue
π£ 6. Psychological Impact
Visible rashes can cause low self-esteem, embarrassment, and anxiety or depression
Especially significant in adolescents or chronic cases
β« 7. Ulceration & Scarring
Common in stasis dermatitis or infected dyshidrotic dermatitis
Deep ulcers may lead to scars or long-term skin damage
π KEY POINTS ON DERMATITIS
β Definition: Dermatitis is inflammation of the skin, characterized by redness, itching, swelling, and lesions.
β Main Causes:
Allergens, irritants, infections, genetics, autoimmune factors, and stress
π Definition, Causes, and Types (Infectious & Non-Infectious)
β Definition:
Dermatoses (plural of dermatosis) refer to any abnormal skin condition or disease that affects the epidermis, dermis, or subcutaneous tissues. It is a broad, non-specific term used to describe various inflammatory, infectious, allergic, autoimmune, or neoplastic skin disorders.
π§Ύ Dermatosis β dermatitis (dermatitis is just one type of dermatosis)
π Causes of Dermatoses:
Dermatoses may result from:
β οΈ Cause
π Examples
Infections
Bacteria, viruses, fungi, parasites
Allergies
Contact with allergens, food, environmental triggers
Autoimmune diseases
Lupus, psoriasis, pemphigus
Environmental factors
Sunlight, humidity, irritants, heat
Genetic predisposition
Atopic dermatitis, ichthyosis
Systemic illness
Diabetes, liver or kidney disease
Nutritional deficiencies
Pellagra (niacin), scurvy (vitamin C)
Drugs and chemicals
Reactions to medications or topical agents
Psychogenic factors
Stress-induced itching or lichen simplex
π¬ TYPES OF DERMATOSES
Dermatoses are broadly divided into two categories:
π¦ I. Infectious Dermatoses
Skin diseases caused by microorganisms (bacteria, fungi, viruses, parasites)
β A. Bacterial Dermatoses
Impetigo β superficial infection (Staph/Strep) with honey-colored crusts
Cellulitis β deep skin infection with redness, warmth, swelling
Erysipelas β superficial streptococcal skin infection with raised borders
Folliculitis β infection of hair follicles
Furuncle/Carbuncle β deeper abscesses
β B. Fungal Dermatoses
Tinea (ringworm) β dermatophyte infection of skin, nails, or scalp
Candidiasis β yeast infection, commonly in skin folds or mucosa
Skin manifestations of internal cancers (e.g., paraneoplastic dermatoses)
π¬ PATHOPHYSIOLOGY OF DERMATOSES
The pathophysiology of dermatoses varies by the underlying cause (infectious vs non-infectious), but most share common pathways involving inflammation, immune response, or tissue damage.
β A. Infectious Dermatoses
Bacterial:
Bacteria invade the epidermis/dermis through breaks in the skin (cuts, insect bites)
Immune cells (neutrophils/macrophages) respond β pus formation, redness, warmth, swelling
Toxins may cause tissue necrosis or systemic symptoms
Fungal:
Dermatophytes, yeasts (like Candida) digest keratin in skin/hair/nails
Cause inflammation, scaling, itching, and discoloration
Immunocompromised patients are at higher risk
Viral:
Viruses infect epidermal cells, leading to vesicle or wart formation
Herpes viruses (HSV, VZV) can remain dormant and reactivate later
Local immune response causes inflammation and pain
Parasitic:
Parasites like mites or lice burrow into or live on the skin
markdownCopyEdit - Oral antibiotics (e.g., **cephalexin**, **amoxicillin-clavulanate**) for cellulitis, abscesses
- Maintain hygiene, wound care |
| Fungal | – Topical antifungals (e.g., clotrimazole, ketoconazole) – Oral antifungals (e.g., fluconazole, terbinafine) for extensive tinea or nail infections – Dry the skin thoroughly to prevent recurrence | | Viral | – Antivirals (e.g., acyclovir, valacyclovir) for herpes simplex/zoster – Cryotherapy or salicylic acid for warts – Molluscum contagiosum may resolve on its own | | Parasitic | – Permethrin 5% cream or ivermectin for scabies – Malathion or permethrin lotion for pediculosis (lice) – Antiprotozoal drugs (e.g., amphotericin B) for leishmaniasis |
Educate the patient on trigger avoidance and skincare
Address emotional and psychosocial concerns
ποΈ I. Assessment (Subjective and Objective)
β Subjective Data:
Complaint of itching, burning, pain, or skin tightness
Past history of allergies, infections, or autoimmune disease
Exposure to irritants, allergens, new medications, or travel
Impact on daily life, self-image, and mood
β Objective Data:
Inspect skin for:
Lesion type (macules, papules, vesicles, pustules, plaques, ulcers)
Distribution and location
Presence of scaling, crusting, oozing, bleeding
Signs of infection (redness, warmth, pus, odor)
Assess hair, nails, and mucous membranes
Monitor vital signs (fever may suggest systemic infection)
π§Ύ II. Nursing Interventions
πΉ 1. Skin Care and Symptom Relief
Apply topical medications (antibiotics, antifungals, corticosteroids) as prescribed
Use cool compresses, calamine lotion, or colloidal oatmeal baths to relieve itching
Keep affected area clean and dry
Avoid friction, tight clothing, and scratching
Encourage use of moisturizers or emollients after bathing
πΉ 2. Infection Prevention
Use gloves during dressing changes or handling infected lesions
Maintain aseptic technique for wound care
Monitor for secondary infections (swelling, pus, fever)
Isolate patients with highly contagious dermatoses (e.g., scabies, impetigo) if needed
Educate on hand hygiene and hygiene of personal items
πΉ 3. Medication Administration
Administer:
Oral antihistamines (e.g., cetirizine, diphenhydramine) for pruritus
Systemic antibiotics, antivirals, antifungals, corticosteroids if prescribed
Observe for side effects: GI upset, drowsiness, allergic reactions
Reinforce adherence to treatment regimen, especially in chronic dermatoses
πΉ 4. Patient and Family Education
Instruct patient to:
Avoid known triggers (e.g., allergens, irritants, food, weather)
Use hypoallergenic soaps and mild detergents
Avoid self-medicating or overuse of topical steroids
Perform proper skin hygiene without over-washing
Avoid scratching or picking at lesions to prevent infection or scarring
Educate family if the condition is contagious (e.g., scabies, fungal infections)
πΉ 5. Psychosocial Support
Address body image issues and self-esteem concerns
Support coping with chronic conditions (e.g., psoriasis, vitiligo)
Encourage support groups or counseling if needed
Promote compliance by building trust and involving the patient in care
π III. Evaluation (Expected Outcomes):
β Skin lesions reduce in size, redness, and discomfort β Patient reports less itching, better sleep, and improved mood β No signs of secondary infection or complication β Patient adheres to treatment, hygiene, and lifestyle advice β Emotional needs are addressed; patient is confident and reassured
β οΈ COMPLICATIONS OF DERMATOSES
If dermatoses are not identified, treated, or controlled properly, they may lead to the following complications:
π¦ 1. Secondary Bacterial Infections
Occur due to scratching, poor hygiene, or improper treatment
Common organisms: Staphylococcus aureus, Streptococcus pyogenes
May result in cellulitis, abscess, impetigo, or sepsis in severe cases
𧱠2. Lichenification (Skin Thickening)
Repeated scratching or rubbing leads to thickened, leathery skin
Seen in chronic eczema, neurodermatitis
π― 3. Hyperpigmentation or Hypopigmentation
Healing skin may leave dark spots (post-inflammatory hyperpigmentation)
Light spots may occur in vitiligo or after severe inflammation
π 4. Chronicity and Recurrence
Chronic dermatoses (e.g., psoriasis, atopic dermatitis) have repeated flare-ups
Can affect quality of life, sleep, work, and emotional well-being
π₯ 5. Psychological Impact
Embarrassment, anxiety, depression, or social withdrawal due to visible lesions
Especially in adolescents or those with facial/body involvement
𧬠6. Scarring and Ulceration
Improper treatment of infected or autoimmune dermatoses (e.g., bullous pemphigoid) can lead to permanent scars or ulcers
π§ͺ 7. Drug Side Effects
Long-term use of topical steroids may cause:
Skin thinning (atrophy)
Stretch marks
Steroid-induced acne or perioral dermatitis
Systemic immunosuppressants may lead to infection risk
π KEY POINTS ON DERMATOSES
β Definition: Dermatoses are any non-specific skin diseases, which may be infectious or non-infectious
Acne is a chronic inflammatory skin disorder of the pilosebaceous unit (hair follicle + sebaceous gland), characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and cysts. It primarily affects adolescents but can occur at any age.
π Most commonly appears on the face, chest, shoulders, and back, where sebaceous glands are most active.
π Causes of Acne:
Acne is a multifactorial condition involving several interrelated mechanisms:
πΉ 1. Increased Sebum Production
Triggered by hormones (especially androgens during puberty)
Sebaceous glands enlarge and produce excess oil
πΉ 2. Follicular Hyperkeratinization
Dead skin cells clump together and block the hair follicle opening
Leads to formation of comedones (open = blackhead, closed = whitehead)
πΉ 3. Bacterial Colonization
Cutibacterium acnes (formerly Propionibacterium acnes) colonizes the blocked follicles
Breaks down sebum into irritating fatty acids β inflammation
πΉ 4. Inflammatory Response
Immune system responds to bacteria and blockage β causes red, swollen papules, pustules, or nodules
πΉ 5. Hormonal Factors
Puberty, menstrual cycle, PCOS, or use of androgenic steroids increase acne risk
πΉ 6. Other Contributing Factors
β οΈ Factor
π Details
Genetic predisposition
Family history of acne increases risk
Stress
Increases cortisol and worsens inflammation
Diet
High glycemic index foods, dairy, or chocolate may aggravate acne in some
Medications
Steroids, lithium, phenytoin, isoniazid
Cosmetics
Oil-based or comedogenic products can block pores
Environmental
Humidity, sweat, and pollution may exacerbate acne
π’ Types of Acne (Acne Vulgaris)
π Based on Lesion Type, Severity, and Special Conditions
π· I. Based on Lesion Type
1οΈβ£ Non-Inflammatory Acne
Characterized by comedones (no redness or swelling)
πΉ Types:
Open comedones (blackheads):
Hair follicles plugged with sebum + dead cells
Surface remains open and oxidizes β dark appearance
Closed comedones (whiteheads):
Follicle plugged but covered by skin
Appears as small, skin-colored bumps
2οΈβ£ Inflammatory Acne
Characterized by redness, swelling, and pain due to immune response and bacterial activity
πΉ Types:
Papules: Small, red, tender bumps
Pustules: Similar to papules, but filled with pus (yellow/white center)
Nodules: Large, painful, solid lumps deep within the skin
Cysts: Deep, pus-filled, inflamed lesions; may scar
Few comedones, occasional papules/pustules, no scarring
Moderate
More widespread comedones, papules, and pustules
Severe
Multiple inflamed nodules, cysts, possible scarring
π΅ III. Special Types of Acne
β 1. Acne Conglobata
Severe, chronic, disfiguring acne
Numerous nodules, abscesses, and cysts interconnected under the skin
Often leads to deep scarring
More common in males and may be associated with steroid abuse
β 2. Acne Fulminans
Sudden, severe ulcerative acne with systemic symptoms (fever, joint pain)
Occurs mainly in young males
May be a hypersensitivity reaction
Requires systemic steroids and antibiotics
β 3. Acne Mechanica
Triggered by heat, friction, or pressure on the skin
Common in athletes (e.g., from helmets, straps, backpacks)
Appears as papules or pustules on pressure areas
β 4. Acne Cosmetica
Caused by comedogenic cosmetic products
Common in women; lesions are usually non-inflammatory
Usually affects forehead, cheeks, and chin
β 5. Hormonal Acne
Seen in teenagers, adult women, or PCOS patients
Worsens before menstruation
Commonly located on jawline, chin, and neck
May need hormonal therapy (e.g., OCPs, anti-androgens)
β 6. Drug-Induced Acne
Caused by medications such as:
Steroids (steroid acne)
Isoniazid, lithium, phenytoin
Typically monomorphic (lesions look similar), often sudden onset
𧬠Pathophysiology of Acne (All Types)
β Overview of Acne Pathophysiology
All types of acne share a common core mechanism, which involves the pilosebaceous unit (hair follicle + sebaceous gland). Acne begins with blockage and inflammation of this unit due to multiple interacting factors:
π Step-by-Step Mechanism (Common to All Types):
β Sebum Production
Stimulated by androgens during puberty or hormonal imbalance
Sebaceous glands secrete excess oil
Follicular Hyperkeratinization
Increased turnover of skin cells in the follicle
Cells stick together and block the follicular opening β comedone formation
Bacterial Colonization
Cutibacterium acnes (formerly Propionibacterium acnes) thrives in sebum-rich environment
Produces enzymes and pro-inflammatory factors
Inflammation
Body responds with immune cells β swelling, redness, pus formation
Acne presents with different types of lesions based on severity and skin response. Symptoms typically affect areas with high sebaceous (oil) gland density: face, chest, shoulders, upper back.
π· A. Types of Acne Lesions
π Lesion Type
π Description
Open comedones
Blackheads β open pores filled with oxidized sebum and keratin
Closed comedones
Whiteheads β clogged pores beneath the skin surface
Papules
Small, red, tender bumps without pus
Pustules
Papules filled with pus (white/yellow center)
Nodules
Large, painful, solid lumps under the skin
Cysts
Deep, pus-filled lesions; soft and painful; may scar
πΆ B. Associated Symptoms
Oily skin (seborrhea)
Itching or tenderness in inflamed areas
Pain in deeper nodules or cysts
Scarring or pigmentation (especially in darker skin types)
Psychosocial effects: anxiety, embarrassment, low self-esteem (especially in adolescents)
π Common Sites of Acne:
Face (forehead, cheeks, chin, jawline)
Back (bacne)
Chest
Shoulders and upper arms
Neck and jawline (especially in hormonal acne)
π§ͺ Diagnosis of Acne
Diagnosis is primarily clinical β based on visual inspection and history.
β 1. History-Taking
Onset, duration, and progression of acne
Menstrual cycle-related flares (hormonal acne)
Use of cosmetics, topical products, or medications
Family history of acne or scarring
Presence of stress, diet patterns, or endocrine disorders (e.g., PCOS)
β 2. Physical Examination
Evaluate type and distribution of lesions: comedones, pustules, nodules, cysts
Check for post-inflammatory pigmentation, scars, or excoriations
Look for signs of acne conglobata or fulminans in severe cases
β 3. Grading the Severity (for treatment planning)
Mild: mostly comedones Β± few papules
Moderate: comedones, papules, and pustules
Severe: nodules, cysts, abscesses, or scarring
β 4. Investigations (if indicated):
πΉ Hormonal Workup (for females with hormonal acne or irregular periods):
Evaluate response to medications and adjust if necessary
Reinforce long-term adherence even after improvement
Counsel on sun protection, especially if using retinoids or after procedures
π III. Evaluation (Expected Outcomes)
β Reduction in acne lesions and inflammation β Improved skin appearance and patient satisfaction β Patient verbalizes understanding of medications and skin care β No signs of secondary infection or scarring β Better emotional and psychological well-being
β οΈ Complications of Acne
If untreated, poorly managed, or in severe cases, acne can lead to both physical and psychological complications:
β A. Physical Complications
π₯ Complication
π Description
Scarring
Depressed (ice-pick, boxcar, rolling) or hypertrophic/keloid scars after cystic acne
Post-inflammatory hyperpigmentation
Dark spots left after acne heals; more common in darker skin tones
Post-inflammatory hypopigmentation
Light spots where acne was inflamed; seen in healing stage
Secondary bacterial infection
Especially from squeezing or picking lesions; may lead to cellulitis or abscess
Sebaceous hyperplasia
Enlarged oil glands after chronic inflammation
Acne fulminans
Rare, severe, ulcerative acne with systemic symptoms (fever, joint pain)
Chronicity/recurrence
Recurrent flares despite treatment, often hormonal or medication-related
β B. Psychological Complications
Depression or anxiety due to facial disfigurement
Social withdrawal, low self-esteem, poor body image
Increased risk of emotional stress, especially in adolescents and young adults
π Key Points Summary of Acne (Acne Vulgaris)
β Definition: A chronic inflammatory disorder of the pilosebaceous unit involving comedones, papules, pustules, nodules, or cysts
β Common Sites: Face, chest, shoulders, back
β Causes:
β Sebum (androgens)
Follicular plugging
C. acnes bacteria
Inflammation
Genetics, diet, stress, cosmetics, hormones
β Types:
Non-inflammatory: blackheads, whiteheads
Inflammatory: papules, pustules, nodules, cysts
Special types: hormonal, cosmetic, mechanical, drug-induced, conglobata
An allergy is an abnormal immune response to a substance (called an allergen) that is harmless to most people. The immune system overreacts, producing histamine and other chemicals, leading to inflammation and allergy symptoms.
π¬ It is a hypersensitivity reaction, usually of Type I (immediate hypersensitivity), mediated by IgE antibodies.
π§ Key Concept:
In allergies, the immune system treats a non-harmful substance (like dust or pollen) as a threat, triggering a reaction.
π Causes of Allergies (Common Allergens)
Allergens can be inhaled, ingested, injected, or come into skin contact.
Seen in healthcare workers, hairdressers, lab technicians, and farmers
π’ Types of Allergies
Allergies can be classified into clinical types based on how allergens enter the body, and what systems they affect. Most are IgE-mediated hypersensitivity reactions (Type I).
Seen in professionals exposed to chemicals, latex, hair dyes, dust, or animal proteins
Examples:
Latex allergy in healthcare workers
Asthma in bakers (flour dust)
Contact dermatitis in hairdressers or cleaners
𧬠8. Allergic Reactions due to Immune Conditions
Atopic Dermatitis (Eczema): Chronic itchy inflammation of skin
Eosinophilic Esophagitis: Food allergy causing inflammation of the esophagus
Allergic Conjunctivitis: Itchy, watery, red eyes due to airborne allergens
𧬠Pathophysiology of Allergies
Allergic reactions are hypersensitivity responses of the immune system to substances that are usually harmless (called allergens). The most common allergic response is Type I Hypersensitivity, which is IgE-mediated and occurs rapidly after exposure.
π Step-by-Step Pathophysiology (Type I Hypersensitivity)
β 1. First Exposure (Sensitization Phase)
The allergen (e.g., pollen, food protein, dust mite) enters the body via skin, inhalation, ingestion, or injection.
It is recognized by antigen-presenting cells (APCs), which process the allergen and present it to T-helper cells (Th2 type).
Th2 cells stimulate B lymphocytes to produce IgE antibodies specific to the allergen.
The produced IgE antibodies bind to receptors (FcΞ΅RI) on the surface of mast cells and basophils, primarily in the skin, lungs, and mucosa.
π§ The person is now sensitized to that allergen β no reaction yet, but the immune system is primed.
β 2. Re-Exposure (Activation Phase)
Upon re-exposure to the same allergen:
The allergen cross-links with the IgE antibodies on mast cells/basophils.
This causes degranulation β the mast cells release histamine, leukotrienes, prostaglandins, and cytokines.
β 3. Inflammatory Response (Effector Phase)
These chemical mediators cause the classic allergic symptoms:
Anaphylaxis β severe hypotension, airway narrowing, life-threatening
π« Other Types of Hypersensitivity Involved in Allergies
π’ Type
π Mechanism
π§Ύ Examples
Type I
IgE-mediated, immediate
Asthma, hay fever, anaphylaxis
Type II
IgG/IgM-mediated cytotoxic (less common)
Drug-induced hemolysis
Type III
Immune complex-mediated
Serum sickness, Arthus reaction
Type IV
Delayed-type, T-cell-mediated
Contact dermatitis, TB skin test
π Signs and Symptoms & Diagnosis of Allergies
β I. Signs and Symptoms of Allergies
Allergic reactions vary in severity and depend on the type of allergen, route of exposure, and individual sensitivity. Symptoms may be localized, systemic, mild, or life-threatening.
π· 1. Respiratory Allergies
β€ Allergic Rhinitis (Hay Fever):
Sneezing
Runny or congested nose
Itchy eyes, nose, throat
Watery or red eyes
Postnasal drip
Fatigue (due to poor sleep)
β€ Allergic Asthma:
Wheezing
Shortness of breath
Chest tightness
Cough (especially at night or early morning)
π½οΈ 2. Food Allergies
Itching or tingling in the mouth
Swelling of lips, tongue, or throat
Hives, redness, or eczema
Abdominal pain, vomiting, diarrhea
Difficulty breathing or anaphylaxis
π 3. Drug Allergies
Skin rash or hives
Itching or fever
Swelling of face or extremities
Anaphylaxis (severe cases)
π 4. Insect Sting Allergies
Local: Redness, swelling, pain at sting site
Systemic: Hives, difficulty breathing, dizziness, drop in BP β anaphylaxis
𧴠5. Skin Allergies
β€ Urticaria (Hives):
Raised, red, itchy welts
Often migratory and vary in shape/size
β€ Contact Dermatitis:
Redness, itching, blisters at site of contact
Often delayed (24β48 hours post-exposure)
β οΈ 6. Anaphylaxis (Severe Allergic Reaction)
π Life-threatening emergency!
Rapid onset (minutes to hours)
Swelling of face, tongue, and airway
Difficulty breathing, wheezing
Rapid heartbeat, low BP
Skin rash or hives
Confusion or loss of consciousness
Needs IM epinephrine (EpiPen) immediately
β II. Diagnosis of Allergies
Allergy diagnosis is based on clinical history, physical examination, and specialized tests to identify the specific allergen.
πΉ 1. Detailed History
Onset, duration, and type of symptoms
Timing in relation to food, drugs, seasons, or exposure
GI signs in food allergy: bloating, cramps, vomiting
πΉ 3. Allergy Testing Methods
π§ͺ Test
π Purpose & Notes
Skin Prick Test (SPT)
Identifies immediate-type (IgE-mediated) reactions to allergens
| Intradermal Test | Used for drug or insect allergy testing – More sensitive than SPT but higher risk of reaction | Patch Testing | Detects delayed hypersensitivity (e.g., contact dermatitis) – Applied to the back and left for 48β72 hrs | Blood Tests (RAST / ImmunoCAP) | Measures specific IgE antibodies in serum – Used when skin tests are contraindicated (e.g., eczema, antihistamine use) | Total Serum IgE Levels | May be elevated in allergic patients but not specific | Elimination Diet | Useful in food allergy β remove and reintroduce suspected foods | Oral Food Challenge | Gold standard for diagnosing food allergies – Done under medical supervision due to risk of anaphylaxis | Spirometry or Peak Flow | Assesses lung function in allergic asthma patients
Monitor vital signs, respiratory status, and oxygen saturation
Assess for progression of rash, swelling, or breathing difficulty
Administer prescribed medications:
Antihistamines for itching or hives
Corticosteroids to reduce inflammation
Bronchodilators for asthma symptoms
Epinephrine IM if anaphylaxis occurs
πΉ 2. Emergency Response for Anaphylaxis
Position patient flat with legs elevated (unless breathing is impaired)
Administer IM epinephrine immediately (EpiPen or injection)
Provide oxygen therapy and start IV fluids if needed
Prepare for intubation or advanced airway management if airway is compromised
Stay with patient and monitor closely until stabilized
πΉ 3. Patient Education
Teach the patient:
To identify and avoid known allergens
Proper use of prescribed medications (e.g., antihistamines, inhalers, nasal sprays)
To always carry an EpiPen if at risk for anaphylaxis
Early signs of allergic reaction and when to seek emergency care
Importance of wearing a medical alert bracelet
π Also educate family members or caregivers in the use of an epinephrine auto-injector.
πΉ 4. Skin and Environmental Care
For skin allergies: apply cool compresses, use hypoallergenic moisturizers
Advise using unscented soaps and laundry detergents
Educate on dust mite control: encase pillows/mattresses, wash linens in hot water
Use HEPA filters, avoid pets if allergic, limit outdoor exposure during high pollen seasons
πΉ 5. Emotional and Psychosocial Support
Reassure and calm the patient, especially during acute reactions
Address anxiety and fear related to repeated or severe allergic episodes
Refer to allergy support groups if needed
Encourage compliance with long-term treatments (e.g., immunotherapy)
π III. Evaluation (Expected Outcomes)
β Allergic symptoms are relieved or controlled β No progression to severe or systemic reaction β Patient understands medications and emergency precautions β Patient successfully avoids allergens and uses preventive strategies β Improved emotional confidence and safety awareness
β οΈ Complications of Allergies
If not properly identified and managed, allergies can lead to various physical and psychological complications:
Eczema, also known as Atopic Dermatitis, is a chronic, relapsing inflammatory skin condition characterized by dry, itchy, red, and inflamed skin, often with crusting or lichenification. It is commonly seen in children but can persist or begin in adulthood.
π¬ It is associated with immune dysregulation and a defective skin barrier.
π Causes of Eczema:
Eczema results from a combination of genetic, environmental, and immunologic factors:
𧬠Cause
π Details
Genetic predisposition
Family history of eczema, asthma, or allergic rhinitis (atopic triad)
Psychosocial effects (low self-esteem, anxiety, social withdrawal)
π Key Points Summary:
β Eczema = chronic inflammatory skin disorder, common in children β Caused by genetic + environmental factors β Itching, redness, dryness, and thickened skin are classic features β Diagnosed clinically, supported by allergy tests if needed β Treatment: Moisturizers, topical steroids, antihistamines, immunomodulators β Nursing care includes trigger avoidance, skin care, education, and infection monitoring β Can lead to infection, sleep issues, or emotional distress
𧬠Pemphigus
π Definition and Causes
β Definition:
Pemphigus is a rare, chronic, autoimmune blistering disorder of the skin and mucous membranes, characterized by the formation of flaccid blisters and erosions due to loss of cohesion between epidermal cells (a process called acantholysis).
π§ In pemphigus, the body produces autoantibodies against desmogleins, which are proteins essential for cell-to-cell adhesion in the skin.
π Key Characteristics:
Superficial, easily ruptured blisters
Painful erosions (especially in the mouth and genitals)
Positive Nikolskyβs sign: Gentle pressure on skin causes epidermal separation
Often starts in oral mucosa, then spreads to skin
π Causes of Pemphigus:
Pemphigus is primarily autoimmune in origin, but several triggers may initiate or worsen the disease.
πΉ 1. Autoimmune Response (Primary Cause)
The body produces IgG autoantibodies against:
Desmoglein 3 (in mucosal pemphigus)
Desmoglein 1 & 3 (in skin + mucosal pemphigus vulgaris)
πΉ 2. Genetic Predisposition
Associated with certain HLA genes (e.g., HLA-DR4, HLA-DR14)
Seen more commonly in people of Mediterranean, Jewish, and Indian descent
πΉ 3. Drug-Induced Pemphigus
Some medications can trigger pemphigus in susceptible individuals:
Penicillamine
Captopril (ACE inhibitor)
Rifampicin
NSAIDs
Phenobarbital
πΉ 4. Environmental Factors (Rare)
Exposure to UV radiation, certain chemicals, or infections may act as triggers
Higher prevalence in certain endemic regions (e.g., Brazil β fogo selvagem, a form of pemphigus foliaceus)
π’ Types of Pemphigus
Pemphigus is classified based on the depth of blistering and the specific target of autoantibodies.
Autoantibodies target desmoglein 1 (found in superficial epidermis)
No mucosal involvement
Blisters are superficial, fragile, often presenting as crusty erosions and scales
Often involves face, scalp, and trunk
π§ Common in endemic areas of Brazil (“fogo selvagem”)
β 3. Pemphigus Vegetans
A rare variant of pemphigus vulgaris
Characterized by vegetating plaques (thick, warty overgrowths)
Seen in axillae, groin, and skin folds
Slower in onset and progression
May be misdiagnosed as fungal infection or psoriasis
β 4. Paraneoplastic Pemphigus (PNP)
Associated with underlying malignancy (e.g., non-Hodgkin lymphoma, chronic lymphocytic leukemia)
Severe mucosal erosions and polymorphic skin lesions
Resistant to treatment and may involve lungs (bronchiolitis obliterans)
𧬠Autoantibodies target multiple antigens, not just desmogleins
β 5. IgA Pemphigus
Rare form with IgA autoantibodies instead of IgG
Blisters arranged in annular or grouped (clustered) patterns
Responds better to dapsone than steroids
Often misdiagnosed as dermatitis herpetiformis
β 6. Drug-Induced Pemphigus
Triggered by drugs like penicillamine, captopril, or rifampicin
Can mimic either pemphigus vulgaris or foliaceus
Usually resolves after withdrawal of the offending drug
𧬠Pathophysiology of Pemphigus (All Types)
Pemphigus is a group of autoimmune blistering disorders that affect the epidermis and mucous membranes, caused by autoantibodies against desmogleins, which are cadherin-type adhesion molecules in the skin.
When these antibodies disrupt desmoglein function, keratinocytes lose adhesion, leading to a process called acantholysis β separation of skin cells β causing blister formation.
π General Mechanism (Common to All Types)
Trigger (genetic predisposition, drug, infection, or cancer in paraneoplastic pemphigus)
Autoimmune activation β production of IgG (or IgA) autoantibodies
Target β antibodies attack desmogleins (DSG1 or DSG3) in desmosomes
Desmosomal disruption β loss of adhesion between epidermal cells (acantholysis)
Blister formation β intraepidermal, flaccid blisters that rupture easily
Inflammatory response β release of cytokines β further skin damage and erosion
π Type-wise Pathophysiology
β 1. Pemphigus Vulgaris (PV)
Autoantibodies: IgG against desmoglein 3 (oral mucosa) and sometimes desmoglein 1 (skin)
Affects deep epidermis (suprabasal layer)
Leads to flaccid bullae and erosions, especially on mucous membranes and skin
Blisters rupture easily due to fragile epidermal adhesion
π§ͺ Histology: Suprabasal clefting and “row of tombstones” appearance of basal cells
β 2. Pemphigus Foliaceus (PF)
Autoantibodies: IgG against desmoglein 1 (expressed in superficial epidermis)
No mucosal involvement, as Dsg1 is not present in mucosa
Affects upper epidermis (subcorneal layer)
Causes shallow erosions, scaling, and crusts rather than deep blisters
π§ͺ Histology: Acantholysis in the superficial epidermis
β 3. Pemphigus Vegetans
Variant of PV
Same autoantibodies (Dsg3 Β± Dsg1)
Exaggerated inflammatory response causes hyperplasia and vegetating plaques
Found in moist, intertriginous areas (groin, axilla)
Associated with malignancies (esp. lymphoma, leukemia)
Causes severe mucocutaneous blistering, polymorphic skin eruptions, and pulmonary involvement (bronchiolitis obliterans)
π§ͺ Histology: Interface dermatitis, necrotic keratinocytes, and acantholysis
β 5. IgA Pemphigus
Autoantibodies of IgA class target desmocollin 1 or other desmosomal components
Results in neutrophilic pustules and intraepidermal cleavage
Pathology differs from PV/PF due to IgA-mediated neutrophilic activation
π§ͺ Histology: Intraepidermal pustules and neutrophilic infiltrates
β 6. Drug-Induced Pemphigus
Medications (e.g., penicillamine, captopril) act as haptens, modifying keratinocyte antigens
Induce IgG autoantibodies similar to PV or PF
Usually resolves on drug withdrawal
π§ͺ Histology and immunofluorescence similar to the type it mimics (PV or PF)
π Signs & Symptoms and Diagnosis of Pemphigus
β I. Signs and Symptoms of Pemphigus (All Types)
The clinical presentation of pemphigus depends on the type and depth of blistering, but most forms involve flaccid blisters, erosions, and painful mucosal involvement.
π· 1. Pemphigus Vulgaris (PV)
Most common and severe type
Initial symptom: painful oral ulcers or mucosal erosions (seen in >90% of cases)
Flaccid skin blisters on normal or erythematous base
CT scan, chest X-ray, or PET-CT to look for underlying malignancy
Lung function tests if respiratory symptoms are present
π Medical Management of Pemphigus
Pemphigus, being an autoimmune blistering disorder, requires immunosuppressive and anti-inflammatory treatment to control disease activity, prevent new blister formation, and promote healing.
π― Goals of Treatment:
Stop the formation of new blisters
Promote healing of existing lesions
Prevent secondary infection
Reduce disease relapses and improve quality of life
β I. First-Line Therapy (Systemic Corticosteroids)
πΉ Oral Prednisolone
Initial dose: 1β2 mg/kg/day (for moderate to severe pemphigus)
High-dose steroids are often needed to control the disease quickly
Once controlled, dose is tapered gradually over weeks/months
πΉ IV Methylprednisolone (Pulse Therapy)
Given in severe or rapidly progressing cases or when oral route is not feasible
Dose: 500β1000 mg/day IV for 3 consecutive days
β οΈ Long-term steroid use requires monitoring for side effects (osteoporosis, diabetes, infections, hypertension, cataracts)
β II. Steroid-Sparing Immunosuppressants (Adjuvant Therapy)
Used to reduce steroid dependency and maintain remission
π Drug
π‘ Use
Azathioprine
Commonly used with corticosteroids
Mycophenolate mofetil
Alternative to azathioprine
Cyclophosphamide
Used in resistant or severe cases
Methotrexate
Occasionally used in mild disease
β III. Biologic Therapy (For Refractory Cases)
πΉ Rituximab (Anti-CD20 monoclonal antibody)
Targets B-cells that produce autoantibodies
Now considered first-line in many guidelines for moderate to severe pemphigus
Given as IV infusions on days 1 and 15, sometimes with maintenance doses
Often combined with corticosteroids
β IV. Adjunctive/Supportive Medications
π Drug/Measure
π Purpose
Antibiotics (topical/oral)
Prevent or treat secondary bacterial infections
Antifungals
For candidiasis due to steroid use
Antivirals
In immunosuppressed patients if herpes or shingles suspected
Calcium/Vitamin D
Prevent steroid-induced osteoporosis
Proton Pump Inhibitors
Protect stomach lining from steroid irritation
Analgesics
Relieve pain from erosions and ulcers
β V. Topical Treatments (for Mild or Localized Lesions)
Topical corticosteroids: e.g., clobetasol or betamethasone
Antiseptic mouthwashes (e.g., chlorhexidine) for oral lesions
Barrier creams or emollients to soothe inflamed skin
Wound dressings to protect eroded or infected areas
π Special Considerations for Paraneoplastic Pemphigus (PNP)
Requires treatment of underlying malignancy
Often resistant to conventional pemphigus therapy
May need aggressive immunosuppression and cancer-directed therapy
π οΈ Surgical Management of Pemphigus
π General Note:
Pemphigus is an autoimmune condition, and thus, surgery is not a primary treatment modality. However, surgical interventions may be required in specific situations to manage complications or aid in supportive care.
β When Surgical Intervention Is Considered:
πΉ 1. Wound Care and Debridement
Indicated for:
Extensive skin erosions with crusting
Secondary bacterial infections
Necrotic tissue in chronic, non-healing ulcers
Procedure:
Gentle debridement of necrotic skin under sterile conditions
Aseptic dressing changes post-debridement
May be done in an outpatient or minor OT setting
πΉ 2. Biopsy for Diagnosis
Punch or incisional skin biopsy is essential for:
Histopathology
Direct immunofluorescence (DIF)
Taken from the edge of a fresh lesion (not ulcerated area)
πΉ 3. Management of Superinfected Lesions or Abscesses
If a blister site becomes secondarily infected and forms an abscess:
Incision and drainage (I&D) may be required
Followed by antibiotics and sterile dressings
πΉ 4. Surgical Management of Underlying Malignancy (in Paraneoplastic Pemphigus)
In cases of PNP, surgery may be needed to:
Remove the underlying tumor (e.g., lymphoma, thymoma)
Often part of oncological management, which may improve skin symptoms indirectly
πΉ 5. Cosmetic or Reconstructive Surgery (Rare)
Considered in long-term survivors with:
Severe scarring or disfigurement
Chronic non-healing erosions or skin contractures
β οΈ These are typically done after the disease is in remission and well-controlled.
β οΈ Surgical Risks in Pemphigus Patients:
Poor wound healing due to immunosuppressive therapy
High infection risk
Skin fragility makes surgical handling more difficult
Post-op corticosteroid adjustment may be required to prevent flare-up
Consider enteral feeding if oral intake is severely compromised
πΉ 5. Medication Administration
Administer steroids, immunosuppressants, and analgesics as prescribed
Monitor for side effects of corticosteroids:
Hyperglycemia, mood swings, infections, GI bleeding
Provide gastroprotective agents (e.g., PPIs)
Ensure adherence to the full course of therapy
πΉ 6. Pain and Comfort Management
Use analgesics appropriately
Apply cool compresses for relief
Provide calm, quiet environment to reduce stress
πΉ 7. Emotional and Psychosocial Support
Provide emotional support for body image issues
Educate patient and family about the chronic nature of the disease
Refer to support groups or counseling if needed
Address fear of relapse, especially during steroid tapering
πΉ 8. Health Education and Discharge Planning
Teach patient to:
Recognize signs of flare-ups and infection
Avoid skin trauma and harsh soaps/chemicals
Maintain regular follow-ups and medication compliance
Encourage stress management and a healthy lifestyle
π III. Evaluation (Expected Outcomes)
β Wounds and mucosal lesions begin to heal β No signs of new blister formation β Patient remains infection-free β Pain is effectively managed β Patient and family demonstrate understanding of disease and treatment β Emotional needs are addressed; patient has improved quality of life
β οΈ Complications of Pemphigus
If left untreated or poorly managed, pemphigus can lead to serious, even life-threatening consequences:
β 1. Secondary Skin Infections
Most common complication
Blisters and erosions act as portals for bacterial, viral, or fungal infections
Can lead to cellulitis, sepsis, or impetigo
β 2. Fluid and Electrolyte Imbalance
Due to extensive weeping wounds and erosions
Risk of dehydration, hyponatremia, and hypovolemia
β 3. Nutritional Deficiencies
Painful oral ulcers impair chewing and swallowing
Leads to weight loss, protein-energy malnutrition, and vitamin deficiencies
Immunosuppression β increased risk of infections
β 5. Eye Involvement (Paraneoplastic Pemphigus)
Can lead to conjunctivitis, corneal scarring, or even blindness
β 6. Respiratory Complications
Seen in Paraneoplastic Pemphigus
May develop bronchiolitis obliterans, a serious lung disease with poor prognosis
β 7. Psychological Impact
Chronic illness and skin disfigurement β depression, anxiety, low self-esteem
May cause social isolation and reduced quality of life
π Key Points Summary: Pemphigus
β Pemphigus is a chronic autoimmune blistering disorder β Caused by IgG autoantibodies against desmogleins (1 and/or 3) β leads to acantholysis β Pemphigus vulgaris is the most common and involves oral and skin lesions β Pemphigus foliaceus is superficial and lacks mucosal involvement β Paraneoplastic pemphigus is severe and associated with malignancy β Classic signs: flaccid bullae, erosions, positive Nikolskyβs sign β Diagnosed with Tzanck smear, skin biopsy, and direct immunofluorescence β Treated with corticosteroids, immunosuppressants, rituximab, and supportive care β Nursing care focuses on wound care, infection prevention, oral hygiene, nutrition, and emotional support β Major complications include infection, steroid toxicity, dehydration, and psychosocial distress
πΏ Psoriasis
π Definition, Causes, and Types
β Definition:
Psoriasis is a chronic, autoimmune, inflammatory skin disorder characterized by accelerated proliferation of skin cells, leading to the formation of thick, red, scaly plaques. It is non-infectious and follows a relapsing-remitting course.
π¬ It results from an immune-mediated attack on the skin, especially involving T-cells and cytokines (like TNF-Ξ±, IL-17, and IL-23).
π Causes and Risk Factors of Psoriasis:
Psoriasis is multifactorial, with both genetic and environmental contributors.
πΉ 1. Genetic Factors
Family history of psoriasis (seen in ~30% of cases)
Linked to genes like HLA-Cw6
πΉ 2. Immune Dysfunction
Autoimmune process involving hyperactivation of T-cells
Causes inflammation and rapid skin turnover
πΉ 3. Environmental Triggers
β οΈ Trigger
π Description
Infections
Streptococcal throat infection (esp. in guttate psoriasis)
Stress
Worsens flare-ups
Injury to skin
Koebner phenomenon β new lesions form at trauma sites
Medications
Lithium, beta-blockers, antimalarials, NSAIDs
Weather
Cold, dry weather aggravates psoriasis
Smoking & Alcohol
Increases severity and flare frequency
Hormonal changes
Puberty or menopause may influence onset
π’ Types of Psoriasis
Psoriasis can present in various clinical forms:
β 1. Plaque Psoriasis (Psoriasis Vulgaris) β Most Common
Thick, red plaques with silvery-white scales
Common on elbows, knees, scalp, and lower back
Often symmetrical
β 2. Guttate Psoriasis
Small, drop-like red lesions with fine scales
Commonly appears after streptococcal infection
Mostly seen in children and young adults
β 3. Inverse (Flexural) Psoriasis
Occurs in skin folds: armpits, groin, under breasts
Smooth, shiny, red patches without scales
Can be confused with fungal infections
β 4. Pustular Psoriasis
White pustules surrounded by red skin
Can be localized (palms/soles) or generalized (life-threatening)
May be triggered by sudden withdrawal of steroids
β 5. Erythrodermic Psoriasis
Widespread redness and scaling over most of the body
Medical emergency due to risk of fluid loss, infection, and hypothermia
Often triggered by abrupt discontinuation of psoriasis treatment
Enhance treatment compliance and patient education
Maintain joint mobility (in psoriatic arthritis)
ποΈ I. Nursing Assessment
β Subjective Data:
Complaints of itching, pain, burning, or tightness of skin
History of stress, infection, medication use, family history
Reported difficulty with daily activities, sleep, or social interaction
β Objective Data:
Location and type of lesions (plaques, scaling, pustules, redness)
Presence of nail changes or joint swelling/stiffness
Signs of secondary infection (redness, pus, warmth, fever)
π§Ύ II. Nursing Interventions
πΉ 1. Skin Care and Lesion Management
Apply prescribed topical medications (e.g., corticosteroids, vitamin D analogues)
Keep skin clean, moisturized, and protected
Use lukewarm water and mild, non-irritating soaps
Avoid scratching β trim nails, suggest soft cotton gloves at night
Use occlusive dressings over thick plaques (if prescribed)
πΉ 2. Infection Prevention
Monitor for signs of skin infection: increased redness, pain, or pus
Educate on hand hygiene and skin protection
Use aseptic technique for dressing changes
Administer antibiotics if ordered
πΉ 3. Itch and Discomfort Relief
Provide antihistamines (as prescribed) to relieve itching
Suggest cool compresses or oatmeal baths
Encourage use of soft clothing and avoiding irritating fabrics
πΉ 4. Psychosocial and Emotional Support
Offer emotional reassurance to reduce anxiety, depression, or social withdrawal
Encourage open discussion about body image concerns
Refer to support groups, counseling, or dermatological rehabilitation services
Promote self-care confidence and independence
πΉ 5. Patient Education
Educate the patient and family on:
Nature of disease: chronic, not contagious, may relapse
Importance of regular treatment and follow-up
Identifying and avoiding triggers (stress, infection, smoking, alcohol, cold weather)
Proper use of topical, oral, or injectable medications
Maintaining hydration and healthy diet
πΉ 6. Joint Care (if Psoriatic Arthritis is present)
Encourage range of motion exercises to maintain flexibility
Teach joint protection techniques
Monitor for joint deformities, pain, and swelling
Coordinate with physiotherapy if needed
π III. Evaluation (Expected Outcomes)
β Skin lesions reduce or heal without secondary infection β Patient verbalizes understanding of condition and treatment β Itching and pain are relieved β Patient shows confidence and self-care in managing disease β No signs of complications or flare-ups
β οΈ Complications of Psoriasis
Although psoriasis is primarily a skin disorder, it can lead to significant systemic, psychological, and functional complications if not well-managed.
β A. Dermatologic Complications
π’ Complication
π Description
Secondary skin infections
Scratching or skin barrier breakdown β cellulitis, impetigo
Erythrodermic psoriasis
Severe, life-threatening β widespread redness, dehydration, electrolyte loss
Pustular psoriasis
Can lead to systemic toxicity (fever, malaise, leukocytosis)
Koebner phenomenon
New lesions develop at trauma sites (e.g., cuts, scratches)
β B. Systemic Complications
β οΈ Complication
π Details
Psoriatic arthritis
Inflammatory joint disease in up to 30% of cases β joint deformity, disability
Cardiovascular disease
Increased risk of hypertension, stroke, and heart disease due to chronic inflammation
Metabolic syndrome
Higher incidence of obesity, insulin resistance, dyslipidemia
Eye involvement
Uveitis, conjunctivitis in psoriatic arthritis
β C. Psychological and Quality-of-Life Complications
Depression and anxiety due to chronic disfigurement and social stigma
Sleep disturbances from itching and discomfort
Social withdrawal, embarrassment, and poor self-image
May lead to non-adherence to treatment
π Key Points Summary: Psoriasis
β Psoriasis is a chronic autoimmune skin condition characterized by rapid skin cell turnover and inflammation.
β Most common type: Plaque psoriasis β red plaques with silvery-white scales, commonly on elbows, knees, scalp.
β Other types: Guttate, inverse, pustular, erythrodermic, nail psoriasis, and psoriatic arthritis.
β Causes/triggers include genetic predisposition, infections, stress, trauma, certain drugs, and cold weather.
β Nursing care includes skin care, infection prevention, patient education, and psychosocial support.
β Complications include infection, joint deformities, erythroderma, and emotional distress.
𧬠Malignant Melanoma
β Definition:
Malignant melanoma is a highly aggressive, life-threatening skin cancer that originates from melanocytes, the pigment-producing cells in the basal layer of the epidermis. It is characterized by uncontrolled melanocyte proliferation, with a high potential to invade locally and metastasize early.
π¬ Though less common than basal or squamous cell carcinoma, it causes the majority of skin cancerβrelated deaths.
π Causes and Risk Factors:
π§ͺ Cause/Risk Factor
π‘ Explanation
Ultraviolet (UV) exposure
Excessive sun or tanning bed use β DNA damage in melanocytes
Monitor vital signs, surgical site, and wound healing
Educate patient on wound care and follow-up
Support pain management and mobility
πΉ Skin Care and Observation
Perform regular skin checks
Teach self-examination using ABCDE criteria
πΉ Emotional and Psychological Support
Address fear of recurrence or metastasis
Provide counseling/referral to oncology support groups
Encourage open communication and body image acceptance
πΉ Patient Education
Importance of sun protection (SPF β₯30, clothing, shade)
Avoid tanning beds and direct sunlight
Teach early signs of recurrence or new lesions
β οΈ Complications:
β Complication
π¬ Description
Local recurrence
Cancer may reappear at or near the original site
Metastasis
Spread to lymph nodes, lungs, brain, liver, bones
Lymphedema
Post lymph node removal
Disfigurement
Post-surgical scarring
Immune-related adverse effects
Due to immunotherapy (colitis, hepatitis, pneumonitis)
π Key Points Summary:
β Malignant melanoma = deadliest skin cancer, arises from melanocytes β Risk factors: UV exposure, fair skin, family history, multiple nevi β Types: Superficial spreading, nodular, lentigo maligna, acral lentiginous β Use ABCDE rule for clinical detection β Diagnosis: Biopsy, imaging, node biopsy β Treated by surgical excision, immunotherapy, targeted therapy β Nursing care includes wound care, psychological support, and sun safety education β Watch for recurrence, metastasis, and treatment-related side effects
π§β𦲠Alopecia
π Definition and Causes
β Definition:
Alopecia is a general medical term for hair loss from the scalp or body, which can be temporary or permanent, partial or complete, and caused by a variety of underlying conditions.
π¬ It can affect the hair follicles, the immune system, or the hormonal balance, and may result in thinning, patchy loss, or complete baldness.
π Causes of Alopecia:
Alopecia can result from genetic, autoimmune, hormonal, infectious, nutritional, or drug-related factors. Causes may be primary (directly affecting hair follicles) or secondary (due to systemic conditions or damage).
Hair loss is patchy, with hairs of varying lengths
More common in children and adolescents
β II. Scarring (Cicatricial) Alopecia
In these types, inflammation destroys the hair follicles permanently, leading to irreversible hair loss and scarring of the scalp.
πΉ 1. Lichen Planopilaris
Autoimmune condition; type of lichen planus affecting the scalp
Redness, scaling, follicular plugging, and permanent patchy hair loss
πΉ 2. Discoid Lupus Erythematosus (DLE)
Chronic form of cutaneous lupus
Red, scaly patches that cause scarring, pigment changes, and permanent hair loss
πΉ 3. Central Centrifugal Cicatricial Alopecia (CCCA)
Progressive hair loss starting at the crown and spreading outward
More common in African descent, often associated with hair styling and chemical use
πΉ 4. Folliculitis Decalvans
Chronic bacterial infection of the hair follicles
Presents with pustules, crusts, and eventual scarring hair loss
πΉ 5. Frontal Fibrosing Alopecia
Type of lichen planopilaris
Causes receding hairline, often with eyebrow loss
Affects mostly postmenopausal women
𧬠Pathophysiology of Alopecia
Alopecia arises from disruption of the normal hair growth cycle, inflammation, autoimmunity, or physical damage to hair follicles. The underlying mechanism varies based on the type of alopecia.
β Normal Hair Growth Cycle
Anagen (growth phase) β 85β90% of scalp hair; lasts 2β6 years
Causes premature shift from anagen to telogen phase
Follicle remains intact β potential for regrowth if inflammation is controlled
Associated with other autoimmune diseases (thyroiditis, vitiligo)
πΉ 3. Telogen Effluvium
Sudden physiologic or emotional stress (e.g., illness, surgery, childbirth)
Triggers massive shift of anagen hairs into telogen phase
Results in diffuse shedding approximately 2β3 months after the event
Hair follicles are not destroyed; recovery is often spontaneous
πΉ 4. Anagen Effluvium
Caused by cytotoxic agents (e.g., chemotherapy, radiation)
Disrupts rapidly dividing matrix cells in anagen follicles
Hair shaft narrows and breaks β rapid and diffuse hair loss
Follicle remains intact β regrowth possible after trigger is removed
πΉ 5. Traction Alopecia
Chronic tension on hair (tight hairstyles) damages follicles mechanically
Prolonged traction causes follicular inflammation and miniaturization
May progress to scarring and irreversible loss if not treated early
πΉ 6. Cicatricial (Scarring) Alopecia
Chronic inflammation, infection, or autoimmune damage destroys the follicular stem cells and sebaceous glands
Results in permanent loss of hair follicles and scar formation
Common causes: Lichen planopilaris, Discoid lupus, Folliculitis decalvans
β οΈ Summary of Pathophysiologic Differences
βοΈ Type
π¬ Pathology
Androgenetic
DHT β follicle miniaturization
Alopecia areata
Autoimmune T-cell attack
Telogen effluvium
Stress-induced early telogen shift
Anagen effluvium
Toxic damage to hair matrix cells
Traction alopecia
Physical tension and follicle injury
Scarring alopecia
Destruction of follicles by inflammation β fibrosis
π Signs and Symptoms of Alopecia
The presentation of alopecia varies based on its type, cause, and chronicity. Hair loss may be patchy, diffuse, or complete, and may involve the scalp, body hair, eyebrows, or eyelashes.
β Common Signs & Symptoms Across Types:
π Symptom
π‘ Description
Visible hair loss
Patches or widespread thinning on the scalp or body
Hair thinning
Often noticed in androgenetic alopecia (diffuse in females, receding in males)
Bald patches
Typically seen in alopecia areata β round, smooth areas
Scalp changes
May show redness, scaling, pustules (in infections or scarring alopecia)
Itching or burning
May occur in scarring alopecia, fungal infections, dermatitis
Hair breakage
In traction alopecia or trichotillomania
Exclamation mark hairs
Narrowed hairs seen at the margins of alopecia areata patches
Nail changes (in alopecia areata)
Nail pitting, ridges, or trachyonychia (rough nails)
π Type-specific Clinical Clues:
π§ͺ Type of Alopecia
π Key Features
Androgenetic alopecia
Gradual thinning; male: frontal/crown; female: central scalp
Alopecia areata
Sudden onset of smooth, round bald patches; may regrow or worsen
Telogen effluvium
Diffuse hair shedding 2β3 months after stressor
Anagen effluvium
Sudden, widespread loss during chemotherapy or radiation
Scarring alopecia
Hair loss with redness, pustules, scarring, or skin atrophy
Trichotillomania
Broken hairs of different lengths; often irregular patches
Tinea capitis
Patchy hair loss with scaling, black dots, possible lymphadenopathy
π§ͺ Diagnosis of Alopecia
Diagnosis is primarily clinical, supported by history, examination, and tests to identify the type and cause.
β 1. History Taking
Onset, duration, and pattern of hair loss
Recent illness, emotional or physical stress
Medications, diet, hair care practices
Family history of baldness or autoimmune disease
Any associated symptoms (itching, scaling, systemic signs)
β 2. Physical Examination
Pattern of hair loss (diffuse vs. patchy)
Examine scalp, nails, eyebrows, eyelashes, body hair
Look for signs of inflammation: erythema, scaling, pustules
Hair pull test: gently pull 30β60 hairs from scalp
>6 hairs coming out = positive (suggests active shedding)
β 3. Trichoscopy (Dermatoscopy of Hair and Scalp)
Non-invasive magnified scalp examination
Helps differentiate:
Alopecia areata: yellow dots, exclamation mark hairs
Androgenetic alopecia: hair diameter variability
Scarring alopecia: absence of follicular openings
β 4. Scalp Biopsy
Useful in scarring alopecia or unclear cases
Shows inflammation, scarring, miniaturization, or follicle destruction
β 5. Blood Tests (as indicated)
π§ͺ Test
π‘ Indications
Thyroid profile (TSH, T3, T4)
For thyroid-related hair loss
CBC, iron studies
For anemia or iron deficiency
Vitamin B12, D levels
Nutritional hair loss
ANA, ESR, CRP
Autoimmune screening
Hormonal panel (LH, FSH, testosterone, prolactin)
If PCOS or androgen excess suspected in females
β 6. Fungal Culture / KOH Scraping
Performed in suspected tinea capitis or scalp infections
π Signs and Symptoms of Alopecia
The presentation of alopecia varies based on its type, cause, and chronicity. Hair loss may be patchy, diffuse, or complete, and may involve the scalp, body hair, eyebrows, or eyelashes.
β Common Signs & Symptoms Across Types:
π Symptom
π‘ Description
Visible hair loss
Patches or widespread thinning on the scalp or body
Hair thinning
Often noticed in androgenetic alopecia (diffuse in females, receding in males)
Bald patches
Typically seen in alopecia areata β round, smooth areas
Scalp changes
May show redness, scaling, pustules (in infections or scarring alopecia)
Itching or burning
May occur in scarring alopecia, fungal infections, dermatitis
Hair breakage
In traction alopecia or trichotillomania
Exclamation mark hairs
Narrowed hairs seen at the margins of alopecia areata patches
Nail changes (in alopecia areata)
Nail pitting, ridges, or trachyonychia (rough nails)
π Type-specific Clinical Clues:
π§ͺ Type of Alopecia
π Key Features
Androgenetic alopecia
Gradual thinning; male: frontal/crown; female: central scalp
Alopecia areata
Sudden onset of smooth, round bald patches; may regrow or worsen
Telogen effluvium
Diffuse hair shedding 2β3 months after stressor
Anagen effluvium
Sudden, widespread loss during chemotherapy or radiation
Scarring alopecia
Hair loss with redness, pustules, scarring, or skin atrophy
Trichotillomania
Broken hairs of different lengths; often irregular patches
Tinea capitis
Patchy hair loss with scaling, black dots, possible lymphadenopathy
π§ͺ Diagnosis of Alopecia
Diagnosis is primarily clinical, supported by history, examination, and tests to identify the type and cause.
β 1. History Taking
Onset, duration, and pattern of hair loss
Recent illness, emotional or physical stress
Medications, diet, hair care practices
Family history of baldness or autoimmune disease
Any associated symptoms (itching, scaling, systemic signs)
β 2. Physical Examination
Pattern of hair loss (diffuse vs. patchy)
Examine scalp, nails, eyebrows, eyelashes, body hair
Look for signs of inflammation: erythema, scaling, pustules
Hair pull test: gently pull 30β60 hairs from scalp
>6 hairs coming out = positive (suggests active shedding)
β 3. Trichoscopy (Dermatoscopy of Hair and Scalp)
Non-invasive magnified scalp examination
Helps differentiate:
Alopecia areata: yellow dots, exclamation mark hairs
Androgenetic alopecia: hair diameter variability
Scarring alopecia: absence of follicular openings
β 4. Scalp Biopsy
Useful in scarring alopecia or unclear cases
Shows inflammation, scarring, miniaturization, or follicle destruction
β 5. Blood Tests (as indicated)
π§ͺ Test
π‘ Indications
Thyroid profile (TSH, T3, T4)
For thyroid-related hair loss
CBC, iron studies
For anemia or iron deficiency
Vitamin B12, D levels
Nutritional hair loss
ANA, ESR, CRP
Autoimmune screening
Hormonal panel (LH, FSH, testosterone, prolactin)
If PCOS or androgen excess suspected in females
β 6. Fungal Culture / KOH Scraping
Performed in suspected tinea capitis or scalp infections
π Medical Management of Alopecia
Management depends on the type of alopecia, its cause, extent, and the patientβs age, gender, and preferences. Treatments aim to slow progression, stimulate regrowth, and manage underlying triggers.
Assess for signs of treatment response or complications
Schedule follow-ups for medication titration or specialist consultation (dermatologist, endocrinologist, psychiatrist)
π III. Evaluation (Expected Outcomes)
β Patient reports reduction in hair loss β Patient expresses improved self-esteem and emotional adaptation β Scalp remains free of infection or irritation β Patient demonstrates understanding of treatment and compliance β Nutritional needs are being met β Patient utilizes coping mechanisms and/or cosmetic aids if needed
β οΈ Complications of Alopecia
Although alopecia is non-life-threatening, it can have significant emotional, psychological, dermatologic, and systemic implications, especially when untreated or mismanaged.
β A. Psychological & Social Complications
β Complication
π Details
Low self-esteem and body image issues
Common in both genders; may lead to withdrawal or embarrassment
Depression and anxiety
Especially in alopecia areata and female pattern baldness
Social isolation
Fear of judgment, bullying, or public appearances
Quality of life reduction
Daily stress related to appearance and hair grooming
β B. Physical Complications
𧬠Complication
π‘ Details
Scalp infections
In cases of open follicles, poor hygiene, or tinea capitis
Permanent scarring
Seen in cicatricial alopecia if inflammation destroys follicles
Sunburn or skin damage
Due to loss of hair protection on scalp/eyebrows
Progression of underlying illness
E.g., thyroid disease, lupus, iron deficiency, if left undiagnosed
β C. Treatment-Related Complications
π Issue
β οΈ Concern
Topical irritants (e.g., minoxidil)
Redness, itching, or dermatitis
Steroid overuse
Thinning of skin, systemic side effects
Oral immunosuppressants
Risk of infection, liver/kidney toxicity
Psychotropic drugs
Side effects like drowsiness, mood changes in trichotillomania
π Key Points Summary: Alopecia
β Alopecia = Hair loss condition affecting scalp/body due to genetic, autoimmune, hormonal, nutritional, psychological, or physical causes
Hydrocolloid and alginate dressings β absorb exudate and support moist healing
Honey dressing / collagen dressing β for infected wounds or diabetic ulcers
πΉ Principles:
Keep wound moist, protected, infection-free
Encourage granulation tissue formation
β 6. Cryotherapy
Involves freezing abnormal skin cells using liquid nitrogen
Used in warts, actinic keratosis, skin tags, basal cell carcinoma
β οΈ May cause temporary pain, blistering, or hypopigmentation
β 7. Chemical Peels
Use of chemical agents (like glycolic acid, salicylic acid) to exfoliate damaged skin layers
Commonly used for acne scars, melasma, pigmentation
Requires proper skin preparation and aftercare to avoid burns or infections
β 8. Psychotherapy/Counseling
Vital for patients with alopecia, vitiligo, severe acne, psoriasis
Helps manage body image issues, anxiety, depression
Referrals to mental health professionals or support groups as needed
β 9. Nutritional and Lifestyle Therapy
Encourage diets rich in vitamins A, C, E, zinc, omega-3 fatty acids
Avoid trigger foods in eczema, acne, urticaria
Encourage hydration, sun protection, gentle skincare routine
β 10. Complementary Therapies
πΏ Type
π‘ Uses
Aloe vera
Soothing agent for burns, eczema
Turmeric (curcumin)
Anti-inflammatory properties
Tea tree oil
Antifungal and acne treatment
Oatmeal baths
Itch relief in eczema, dermatitis
Ayurveda/Homeopathy
Popular in chronic conditions (used with caution)
β οΈ Always assess for skin sensitivity or allergies before recommending herbal treatments.
πΏ Alternative Therapies for Integumentary System Disorders
These therapies are used alongside conventional treatments to enhance skin healing, reduce inflammation, and promote well-being in conditions such as eczema, psoriasis, acne, burns, ulcers, dermatitis, and hair loss.
Regular yoga and mindfulness practices improve skin tone, immunity, and healing.
β 8. Natural Topical Packs and Baths
π§ Remedy
π‘ Use
Oatmeal bath
Relieves itching in eczema, dermatitis
Multani mitti (Fuller’s Earth)
Oil control and acne treatment
Sandalwood paste
Cooling and anti-inflammatory
Cucumber and honey mask
Skin hydration and soothing
β 9. Lifestyle Modifications
Avoid harsh soaps, detergents, and hot water baths
Use cotton clothing for eczema and urticaria patients
Encourage daily exercise and sun protection
Sleep hygiene: Skin regenerates best during proper sleep cycles
π Summary Table
π Alternative Therapy
π Benefits
Herbal / Ayurveda
Natural anti-inflammatory, skin healing
Homeopathy
Individualized care for chronic skin diseases
Acupuncture
Balances energy, reduces flares
Aromatherapy
Skin and emotional healing
Nutritional support
Anti-inflammatory & antioxidant protection
Yoga & meditation
Stress control, immune balance
Natural packs/baths
Soothing relief, detox, hydration
π Drugs Used in the Treatment of Integumentary System Disorders
Integumentary system disorders include conditions like eczema, psoriasis, acne, dermatitis, fungal/bacterial infections, alopecia, burns, ulcers, urticaria, and skin cancers. Treatment is based on underlying cause, severity, site, and patientβs response.
β 1. Topical Corticosteroids
πΉ Examples:
Hydrocortisone (mild)
Betamethasone, Clobetasol (potent)
πΉ Uses:
Eczema, psoriasis, dermatitis, allergic reactions
πΉ Action:
Reduces inflammation, itching, and redness
πΉ Nursing Note:
Use sparingly, especially on face/folds
Risk of skin thinning, depigmentation, or tachyphylaxis with prolonged use